Live search
TopFind is fetching the latest matches for your search.
We reviewed 39 live results for tnf inhibitors and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Biologics and Tnf Inhibitors.
Source: Pfizer Private Limited
Description
Abrilada is an HSA-approved adalimumab biosimilar available in Singapore. It is offered in 20mg/0.4ml and 40mg/0.8ml single-dose pre-filled syringes and 40mg/0.8ml pre-filled pens. It provides an alternative for patients requiring TNF blocker therapy for inflammatory diseases.
Best for
biologic therapy, chronic inflammation management and subcutaneous injection
Rating
Source: Viatris / Fujifilm Kyowa Kirin Biologics
Description
Hulio is an adalimumab biosimilar listed in Singapore's National Drug Formulary. It is available in 40mg/0.8ml pre-filled pens and syringes for treating inflammatory conditions such as rheumatoid arthritis and psoriasis.
Best for
immune-mediated disorders, Singapore NDF access and subcutaneous administration
Rating
Source: Samsung Bioepis / Organon
Description
Hadlima is an adalimumab biosimilar widely used for inflammatory diseases. While not a primary registered brand for commercial supply in Singapore, it has significant availability and approval in the United States, Australia, and Canada.
Best for
US healthcare market, Australian pharmaceutical access and Canadian healthcare patients
Rating
| Compare | Abrilada | Hulio | Hadlima |
|---|---|---|---|
| Source | Pfizer Private Limited | Viatris / Fujifilm Kyowa Kirin Biologics | Samsung Bioepis / Organon |
| Description | Abrilada is an HSA-approved adalimumab biosimilar available in Singapore. It is offered in 20mg/0.4ml and 40mg/0.8ml single-dose pre-filled syringes and 40mg/0.8ml pre-filled pens. It provides an alternative for patients requiring TNF blocker therapy for inflammatory diseases. | Hulio is an adalimumab biosimilar listed in Singapore's National Drug Formulary. It is available in 40mg/0.8ml pre-filled pens and syringes for treating inflammatory conditions such as rheumatoid arthritis and psoriasis. | Hadlima is an adalimumab biosimilar widely used for inflammatory diseases. While not a primary registered brand for commercial supply in Singapore, it has significant availability and approval in the United States, Australia, and Canada. |
| Best for | biologic therapy, chronic inflammation management and subcutaneous injection | immune-mediated disorders, Singapore NDF access and subcutaneous administration | US healthcare market, Australian pharmaceutical access and Canadian healthcare patients |
| Tags | |||
| Action | View Details | View Details | View Details |
| Rating |
If you want the most balanced option to start with, I recommend:
"Abrilada from Pfizer Private Limited."
I picked this because An HSA-approved alternative from a major manufacturer, offering standard injection formats.